DSC: Exploring the Safety and Efficacy of Everolimus in PTEN Hamartoma Tumor Syndrome
Nov 7, 2022 ·
2m 1s
New research from the Developmental Synaptopathies Consortium (DSC). This summary is based on a paper published in the journal Human Molecular Genetics on October 15, 2022, titled "A randomized controlled...
show more
New research from the Developmental Synaptopathies Consortium (DSC). This summary is based on a paper published in the journal Human Molecular Genetics on October 15, 2022, titled "A randomized controlled trial of everolimus for neurocognitive symptoms in PTEN hamartoma tumor syndrome."
Read the paper here: https://academic.oup.com/hmg/article/31/20/3393/6589680
Learn more about DSC: https://www1.rarediseasesnetwork.org/cms/dsc
show less
Read the paper here: https://academic.oup.com/hmg/article/31/20/3393/6589680
Learn more about DSC: https://www1.rarediseasesnetwork.org/cms/dsc
Information
| Author | RDCRN |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
